Molly Pulchtopek
Family · West Springfield, MANPI 1942819685
Payments from drug & device makers
Across 163 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$528
- E.r. Squibb & Sons, L.L.C.$360
- Amgen$342
- Pfizer$342
- Merck$290
- Harmony Biosciences LLC$246
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,440100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 21 | $528 |
| E.r. Squibb & Sons, L.L.C. | 17 | $360 |
| Amgen | 17 | $342 |
| Pfizer | 15 | $342 |
| Merck | 16 | $290 |
| Harmony Biosciences LLC | 12 | $246 |
| Boehringer Ingelheim | 10 | $214 |
| Novartis | 9 | $169 |
| Actelion Pharmaceuticals US, Inc. | 5 | $141 |
| AstraZeneca | 7 | $141 |
| Novo Nordisk | 6 | $124 |
| Kiniksa Pharmaceuticals, Ltd. | 6 | $122 |
| Sanofi-aventis U.S. LLC | 2 | $65 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $63 |
| Heartflow, Inc. | 3 | $62 |
| GSK | 3 | $50 |
| Scpharmaceuticals Inc. | 3 | $48 |
| Jazz Pharmaceuticals Inc. | 1 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $20 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Altathera Pharmaceuticals LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$125
How this compares
$3,440 in reported general payments places this provider in the 90th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 91 | $104,714 |
| XareltoRivaroxaban | 30 | $44,612 |
| EntrestoSacubitril/Valsartan | 12 | $21,025 |
| Metoprolol Succinate | 86 | $2,389 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 31 | $1,687 |
| Atorvastatin Calcium | 77 | $1,533 |
| Rosuvastatin Calcium | 41 | $1,059 |
| Flecainide Acetate | 20 | $984 |
| Ezetimibe | 13 | $905 |
| Losartan Potassium | 38 | $539 |
| Lisinopril | 48 | $438 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 23 | $432 |
| Amlodipine Besylate | 41 | $375 |
| Nitroglycerin | 14 | $261 |
| Carvedilol | 24 | $196 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $342 | $104,71491 claims |
| Johnson & JohnsonXarelto | $528 | $44,61230 claims |
| NovartisEntresto | $169 | $21,02512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,320 family providers in Massachusetts.
Other family in West Springfield
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Courtney NixonAmherst$81K
- Elizabeth WalshBrighton$80K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.